Connect with us

Hi, what are you looking for?

Editor's Pick

Biden DHS’s purchase of weapon linked to Havana Syndrome attacks leads House Republicans to demand answers

The Biden administration purchased a pulsed energy weapon suspected of being the type that may have caused ‘Havana Syndrome’ which caused a series of mysterious ailments for U.S. diplomats and government workers in Cuba.

The weapon was bought at the end of the Biden Administration and has since been tested by the Pentagon, Fox News has learned. House Republicans are demanding answers amid reports of the purchase of the device.

In a letter to Homeland Security Kristi Noem, House Committee on Homeland Security Chairman Andrew Garbarino, R-N.Y., is asking for information on the procurement process for the weapon, its costs and the findings associated with its year-long testing related to Havana Syndrome, officially known as Anomalous Health Incidents (AHI).

‘The device in question is described as capable of producing pulsed radio waves and containing Russian components, though it is supposedly not entirely Russian in origin,’ the letter states. ‘Following HSI’s successful acquisition of the device, it was reportedly transferred to DoW, which spent more than a year testing the device and its capabilities.’

Some U.S. intelligence agencies have said a foreign adversary could be behind the mysterious ailment.

Fox News Digital previously reported that Adam, a former government employee whose identity Fox News agreed to protect, is considered to be ‘Patient Zero.’

He was first attacked in December 2016 while living in Havana on assignment. During his time on the Caribbean island, Adam experienced multiple attacks and described pressure to the brain that led to vertigo, tinnitus and cognitive impairment.

‘While assessments from the Intelligence Community (IC) do not conclusively identify the factors causing AHIs or any foreign actor responsible, an assessment from the Office of the Director of National Intelligence (ODNI) presented a majority view concluding that it was ‘very unlikely’ that a foreign actor ‘used a novel weapon or prototype device to harm even a subset of the U.S. Government personnel,’ with five out of seven agencies agreeing with that assessment,’ Garbarino wrote in his letter.

‘However, two agencies dissented from the majority view and assessed that there was a chance that foreign actors may have developed some sort of ‘novel weapon or prototype device’ that could have harmed U.S. personnel,’ he added.

However, the Office of the Director of National Intelligence (ODNI) released the report and held a background call with reporters on Friday explaining that new reporting ‘led two components to shift their assessments about whether a foreign actor has a capability that could cause biological effects consistent with some of the symptoms reported as possible AHIs.’

‘This shift consequently led two IC components to subtly change their overall judgment about whether a foreign actor might have played a role in a small number of events,’ the agency said.

Fox News’ Liz Friden contributed to this report.

This post appeared first on FOX NEWS

    Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!


    By signing up, you're cool with getting emails from us. Don’t worry—your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    You May Also Like

    Investing

    Fisker (NYSE: FSR) stock price has been one of the best-performing electric vehicle (EV) stocks this week even as Tesla slumped. The shares jumped...

    Investing

    Newmont (NYSE: NEM) reported mixed financial results even as the price of gold approached its all-time high. In all, the company’s earnings per share...

    Investing

    The Fox Corporation (NASDAQ: FOX) stock price has been under pressure as investors come to terms with the abrupt firing of Tucker Carlson. The...

    Investing

    NatWest (LON: NWG) share price rose sharply, helped by the strong results from Barclays. The stock jumped to a high of 274.8p, which was...




    Disclaimer: Oldamericanbroker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the-company.


    Copyright © 2026 oldamericanbroker.com | All Rights Reserved